Literature DB >> 26926057

Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.

Carlo Serra1, Jan-Karl Burkhardt1, Giuseppe Esposito1, Oliver Bozinov1, Athina Pangalu2, Antonios Valavanis2, David Holzmann3, Christoph Schmid4, Luca Regli1.   

Abstract

OBJECTIVE: The aim of this study was to quantitatively assess the role of intraoperative high-field 3-T MRI (3T-iMRI) in improving the gross-total resection (GTR) rate and the extent of resection (EOR) in endoscopic transsphenoidal surgery (TSS) for pituitary adenomas.
METHODS: Radiological and clinical data from a prospective database were retrospectively analyzed. Volumetric measurements of adenoma volumes pre-, intraoperatively, and 3 months postoperatively were performed in a consecutive series of patients who had undergone endoscopic TSS. The quantitative contribution of 3T-iMRI was measured as a percentage of the additional rate of GTR and of the EOR achieved after 3T-iMRI.
RESULTS: The cohort consisted of 50 patients (51 operations) harboring 33 nonfunctioning and 18 functioning pituitary adenomas. Mean adenoma diameter and volume were 21.1 mm (range 5-47 mm) and 5.23 cm(3) (range 0.09-22.14 cm(3)), respectively. According to Knosp's classification, 10 cases were Grade 0; 8, Grade 1; 17, Grade 2; 12, Grade 3; and 4, Grade 4. Gross-total resection was the surgical goal (targeted [t]GTR) in 34 of 51 operations and was initially achieved in 16 (47%) of 34 at 3T-iMRI and in 30 (88%) of 34 cases after further resection. In this subgroup, the EOR increased from 91% at 3T-iMRI to 99% at the 3-month MRI (p < 0.05). In the 17 cases in which subtotal resection (STR) had been planned (tSTR), the EOR increased from 79% to 86% (p < 0.05) and GTR could be achieved in 1 case. Intrasellar remnants were present in 20 of 51 procedures at 3T-iMRI and in only 5 (10%) of 51 procedures after further resection (median volume 0.15 cm(3)). Overall, the use of 3T-iMRI led to further resection in 27 (53%) of 51 procedures and permitted GTR in 15 (56%) of these 27 procedures; thus, the GTR rate in the entire cohort increased from 31% (16 of 51) to 61% (31 of 51) and the EOR increased from 87% to 95% (p < 0.05).
CONCLUSIONS: The use of high-definition 3T-iMRI allowed precise visualization and quantification of adenoma remnant volume. It helped to increase GTR and EOR rates in both tGTR and tSTR patient groups. Moreover, it helped to achieve low rates of intrasellar remnants. These data support the use of 3T-iMRI to achieve maximal, safe adenoma resection.

Entities:  

Keywords:  ACTH = adrenocorticotropic hormone; EOR = extent of resection; GH = growth hormone; GTR = gross-total resection; NFA = nonfunctioning pituitary adenoma; PA = pituitary adenoma; STR = subtotal resection; TSS = transsphenoidal surgery; TVDT = tumor volume doubling time; endoscopy; iMRI = intraoperative MRI; intraoperative MRI; pituitary adenoma; t = targeted; transsphenoidal surgery; volumetry

Mesh:

Year:  2016        PMID: 26926057     DOI: 10.3171/2015.12.FOCUS15564

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  13 in total

1.  Intraoperative unfolding and postoperative pruning of the pituitary gland after transsphenoidal surgery for pituitary adenoma: A volumetric and endocrinological evaluation.

Authors:  Victor E Staartjes; Sarah Stricker; Giovanni Muscas; Nicolai Maldaner; David Holzmann; Jan-Karl Burkhardt; Burkhardt Seifert; Christoph Schmid; Carlo Serra; Luca Regli
Journal:  Endocrine       Date:  2018-09-21       Impact factor: 3.633

Review 2.  The experience with transsphenoidal surgery and its importance to outcomes.

Authors:  Jürgen Honegger; Florian Grimm
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 3.  iMRI During Transsphenoidal Surgery.

Authors:  Prashant Chittiboina
Journal:  Neurosurg Clin N Am       Date:  2017-08-18       Impact factor: 2.509

4.  The changing sella: internal carotid artery shift during transsphenoidal pituitary surgery.

Authors:  Carlo Serra; Nicolai Maldaner; Giovanni Muscas; Victor Staartjes; Athina Pangalu; David Holzmann; Michael Soyka; Christoph Schmid; Luca Regli
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

5.  Anesthetic challenges and outcomes for procedures in the intraoperative magnetic resonance imaging suite: A systematic review.

Authors:  Hedwig Schroeck; Tasha L Welch; Michelle S Rovner; Heather A Johnson; Florian R Schroeck
Journal:  J Clin Anesth       Date:  2018-11-08       Impact factor: 9.452

6.  Diabetes insipidus and syndrome of inappropriate antidiuresis (SIADH) after pituitary surgery: incidence and risk factors.

Authors:  Elena L Sorba; Victor E Staartjes; Stefanos Voglis; Lazar Tosic; Giovanna Brandi; Oliver Tschopp; Carlo Serra; Luca Regli
Journal:  Neurosurg Rev       Date:  2020-06-24       Impact factor: 3.042

Review 7.  Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis.

Authors:  Victor E Staartjes; Alex Togni-Pogliorini; Vittorio Stumpo; Carlo Serra; Luca Regli
Journal:  Pituitary       Date:  2021-05-04       Impact factor: 4.107

8.  UniversitätsSpital Zürich: 80 years of neurosurgical patient care in Switzerland.

Authors:  Martin N Stienen; Carlo Serra; Lennart H Stieglitz; Niklaus Krayenbühl; Oliver Bozinov; Luca Regli
Journal:  Acta Neurochir (Wien)       Date:  2017-11-13       Impact factor: 2.216

9.  The Zurich Checklist for Safety in the Intraoperative Magnetic Resonance Imaging Suite: Technical Note.

Authors:  Martin N Stienen; Jorn Fierstra; Athina Pangalu; Luca Regli; Oliver Bozinov
Journal:  Oper Neurosurg (Hagerstown)       Date:  2019-06-01       Impact factor: 2.703

10.  Impact of Intraoperative 3-Tesla MRI on Endonasal Endoscopic Pituitary Adenoma Resection and a Proposed New Scoring System for Predicting the Utility of Intraoperative MRI.

Authors:  Masahiro Tanji; Hiroharu Kataoka; Masahiro Kikuchi; Tatsunori Sakamoto; Fumihiko Kuwata; Mami Matsunaga; Takayuki Nakagawa; Yohei Mineharu; Yoshiki Arakawa; Kazumichi Yoshida; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2020-10-21       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.